A close runner to CUV, in biotech, for shorting is IMU. They just announced some seriously good results from trials, will be interesting to see if this leads to more or less shorting for them.
CUV Price at posting:
$11.16 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
